See other companies on Welcome to the Jungle

CellVoyant

Creating novel stem cell-based therapy

CellVoyant logo
1-20 employees
  • B2B
  • Artificial Intelligence
  • Deep Tech
  • Biology
  • MedTech
Brandon, Bristol, UK

Jump to section

Company mission

Cellvoyant's mission is to cure chronic diseases.

Our take

In the world of stem cell research, only the start and end states of cells are analysed and measured, making the process slow and inefficient. CellVoyant is a company that wants to leverage the possibilities of those transitional phases of stem cells to broaden the usages they have in therapies for diseases, thus expanding the potential stem cells have in medicine.

CellVoyant melds the physical and the digital in its research. Large-scale cell cultures are grown and live imaging of these cultures is combined with data-driven computer vision to predict and encourage the final state of these stem cells. The approach to cultivating stem cell outcomes is designed to control their growth into the adult cell that is needed for specific therapies.

The potential usages of CellVoyant’s research could change the face of medicine worldwide, making it easier and more accessible for patients to gain the adult cells they need. However, the nature of its research means there’s a lot of trial and error so slow progress is expected. Being bootstrapped from launch means that CellVoyant has the backers - and academic leadership team - to thrive in a marketplace with few competitors.

Freddie headshot

Freddie

Company Specialist at Welcome to the Jungle

Benefits

  • Ability to work remotely or in our Bristol, UK headquarters and join bi-annual week-long company off sites

Company values

  • Innovation - We foster a culture of innovation, empowering individuals to think creatively and push boundaries. We actively engage in experimentation, embracing mistakes as learning opportunities. Our drive to challenge assumption propels us forward
  • Agility - We work smarter, not harder. We quickly navigate complex problems, make informed decisions and execute projects with speed and precision. We’re nimble and committed to delivering optimal results in an ever changing landscape
  • Diversity - Our goal is to build a workplace that champions diversity, where every team member feels valued, respected, and empowered. We believe that by fostering an inclusive culture, we create a stronger, more vibrant organisation that can make a positive impact in the world
  • Integrity - We are dedicated to upholding the highest level of integrity, with a strong emphasis on transparency in all our communications. We promote compassion and accountability as integral behaviours within our business

Funding (1 round)

Jan 2024

$9.7m

EARLY VC

Total funding: $9.7m

This company has top investors

Leadership

Rafel E Cazaros

(CEO)

Research Fellow at the Alan Turing Institute, Professor, School of Cellular and Molecular Medicine at the University of Bristol, Co-Founder and Consultant at Adrestia Therapeutics. Previous Group Leader of Pharmacology & Genetics Departments and Cambridge Systems Biology Centre at the University of Cambridge.